| Dr Laura Hays Ferguson, MD | |
|
1 Akron General Ave, Akron, OH 44307-2432 | |
| (330) 344-7040 | |
| (330) 344-1714 |
| Full Name | Dr Laura Hays Ferguson |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 1 Akron General Ave, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043462534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 128753 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Akron General Medical Center | Akron, OH | Hospital |
| Medina Hospital | Medina, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Partners Physician Group | 4183529340 | 488 |
News Archive
According to Millennium Research Group, the global authority on medical technology market intelligence, the recent launch of irrigated-tip catheters into the Japanese market will drive the ablation catheter market by a compound annual growth rate of approximately 15% through 2014.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder according to new research from the University of South Australia.
Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.
› Verified 5 days ago
| Entity Name | Partners Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841239274 PECOS PAC ID: 4183529340 Enrollment ID: O20031202000183 |
News Archive
According to Millennium Research Group, the global authority on medical technology market intelligence, the recent launch of irrigated-tip catheters into the Japanese market will drive the ablation catheter market by a compound annual growth rate of approximately 15% through 2014.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder according to new research from the University of South Australia.
Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Hays Ferguson, MD 224 W Exchange St, Suite 220, Akron, OH 44302-1704 Ph: (330) 344-7040 | Dr Laura Hays Ferguson, MD 1 Akron General Ave, Akron, OH 44307-2432 Ph: (330) 344-7040 |
News Archive
According to Millennium Research Group, the global authority on medical technology market intelligence, the recent launch of irrigated-tip catheters into the Japanese market will drive the ablation catheter market by a compound annual growth rate of approximately 15% through 2014.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder according to new research from the University of South Australia.
Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.
› Verified 5 days ago
Daniel W Satariano, M. D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Dr. Pang Tsui, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Dr. Edward S. Sunoo, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8823 Fax: 330-296-6535 | |
Sheryl J Ontell-silverman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 190 N Union St, Ste 104, Akron, OH 44304 Phone: 330-253-9145 Fax: 330-253-6222 | |
Dr. Tarun Bhalla, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8823 Fax: 330-543-3593 | |
Grace Brown, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-6000 |